Testing effectiveness (Phase 2)Ended earlyNCT02540356
What this trial is testing
Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer
Who this might be right for
Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
Baxalta now part of Shire 2